-+ 0.00%
-+ 0.00%
-+ 0.00%

*Vyne Therapeutics: Repibresib Gel (VYN201) Phase 2b Vitiligo Top-Line Results Expected in Mid-2025 >VYNE

Dow Jones·05/08/2025 12:06:00

Please log in to view news